SIMG
BMRN icon

Sonora Investment Management Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Sonora Investment Management Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$391K Hold
7,218
– – 0.03% 198
2025
Q2 		$397K Hold
7,218
– – 0.03% 192
2025
Q1 		$510K Hold
7,218
– – 0.04% 166
2024
Q4 		$474K Buy
+7,218
New +$483K 0.04% 176

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sonora Investment Management Group's BMRN Position: Q3 2025 in Review

Sonora Investment Management Group held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2025 at 7,218 shares worth $391K. The position accounts for 0.03% of the portfolio, ranked #198.

Sonora Investment Management Group first reported a position in BMRN in Q4 2024 and has held it in 4 quarters since. The position peaked at $510K in Q1 2025. 577 funds tracked by Wall St. Rank hold BMRN as of Q3 2025.

  • Sonora Investment Management Group held 7,218 shares of BioMarin Pharmaceuticals worth $391K as of Q3 2025.
  • Sonora Investment Management Group left its BioMarin Pharmaceuticals share count unchanged in Q3 2025.
  • BioMarin Pharmaceuticals made up 0.03% of Sonora Investment Management Group's portfolio in Q3 2025, its #198 holding.
  • Sonora Investment Management Group first reported a position in BioMarin Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Sonora Investment Management Group's BioMarin Pharmaceuticals position peaked at $510K in Q1 2025.
  • 577 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2025.

Based on Sonora Investment Management Group's 13F filing for Q3 2025, filed 7 Oct 2025.